Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease

被引:71
|
作者
Ajmera, Veeral H. [1 ,2 ]
Liu, Amy [1 ]
Singh, Seema [1 ]
Yachoa, Georg [1 ]
Ramey, Matthew [1 ]
Bhargava, Meera [1 ]
Zamani, Ava [1 ]
Lopez, Scarlett [1 ]
Mangla, Neeraj [1 ]
Bettencourt, Ricki [1 ]
Rizo, Emily [1 ]
Valasek, Mark [3 ]
Behling, Cynthia [4 ]
Richards, Lisa [1 ]
Sirlin, Claude [5 ]
Loomba, Rohit [1 ,2 ]
机构
[1] Univ Calif San Diego, NAFLD Res Ctr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
[4] Sharp Med Grp, Dept Pathol, San Diego, CA USA
[5] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, La Jolla, CA 92093 USA
关键词
TRANSIENT ELASTOGRAPHY; NONINVASIVE DIAGNOSIS; SAMPLING VARIABILITY; HEPATIC STEATOSIS; WEIGHT-LOSS; NAFLD; STEATOHEPATITIS; ACCURATE; BIOPSY; MRI;
D O I
10.1002/hep.30974
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Cross-sectional studies have shown that magnetic resonance elastography (MRE) is accurate in the noninvasive detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD). However, there are limited data on the longitudinal association between an increase in liver stiffness on MRE and fibrosis progression in NAFLD. Therefore, using a well-characterized prospective cohort of patients with biopsy-proven NAFLD, we aimed to examine the longitudinal association between a 15% increase in liver stiffness on MRE and fibrosis progression in NAFLD. Approach and Results This prospective cohort study included 102 patients (62.7% women) with biopsy-proven NAFLD who underwent contemporaneous MRE and liver biopsy at baseline followed by a repeat paired liver biopsy and MRE assessment. The primary outcome was odds of fibrosis progression by one or more stage as assessed by the Nonalcoholic Steatohepatitis Clinical Research Network histologic scoring system. The mean (+/- SD) of age and body mass index (BMI) were 52 (+/- 14) years and 32.6 (+/- 5.3) kg/m(2), respectively. The median time interval between the two paired assessments was 1.4 years (interquartile range 2.15 years). The number of patients with fibrosis stages 0, 1, 2, 3, and 4 was 27, 36, 12, 17, and 10, respectively. In unadjusted analysis, a 15% increase in MRE was associated with increased odds of histologic fibrosis progression (odds ratio [OR], 3.56; 95% confidence interval [CI], 1.17-10.76; P = 0.0248). These findings remained clinically and statistically significant even after multivariable adjustment for age, sex, and BMI (adjusted OR, 3.36; 95% CI, 1.10-10.31; P = 0.0339). A 15% increase in MRE was the strongest predictor of progression to advanced fibrosis (OR, 4.90; 95% CI, 1.35-17.84; P = 0.0159). Conclusions A 15% increase in liver stiffness on MRE may be associated with histologic fibrosis progression and progression from early fibrosis to advanced fibrosis.
引用
收藏
页码:849 / 860
页数:12
相关论文
共 50 条
  • [31] Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
    Kim, Donghee
    Kim, W. Ray
    Talwalkar, Jayant A.
    Kim, Hwa Jung
    Ehman, Richard L.
    RADIOLOGY, 2013, 268 (02) : 411 - 419
  • [32] Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Elastography to Evaluate the Early Effects of Bariatric Surgery on Nonalcoholic Fatty Liver Disease
    Tan, Hong Chang
    Shumbayawonda, Elizabeth
    Beyer, Cayden
    Cheng, Lionel Tim-Ee
    Low, Albert
    Lim, Chin Hong
    Eng, Alvin
    Chan, Weng Hoong
    Lee, Phong Ching
    Tay, Mei Fang
    Kin, Stella
    Chang, Jason Pik Eu
    Bee, Yong Mong
    Goh, George Boon Bee
    INTERNATIONAL JOURNAL OF BIOMEDICAL IMAGING, 2023, 2023
  • [33] Magnetic Resonance Elastography versus Transient Elastography in detection of fibrosis in nonalcoholic fatty liver disease: A systematic review and meta-analysis of individual participant date
    Hsu, C.
    Caussy, C.
    Imajo, K.
    Chen, J.
    Singh, S.
    Kaulback, K.
    Le, M.
    Hooker, J.
    Bettencourt, R.
    Yin, M.
    Sirlin, C.
    Ehman, R. L.
    Nakajima, A.
    Loomba, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S560 - S561
  • [34] Magnetic resonance elastography vs. transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease
    Park, C. C.
    Nguyen, P.
    Hernandez, C.
    Bettencourt, R.
    Ramirez, K. S.
    Fortney, L. E.
    Hooker, J.
    Sy, E.
    Alquiraish, M. H.
    Valasek, M. A.
    Rizo, E.
    Richards, L.
    Brenner, D.
    Sirlin, C. B.
    Loomba, R.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S233 - S233
  • [35] Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD
    Tamaki, Nobuharu
    Munaganuru, Nagambika
    Jung, Jinho
    Yonan, Aed Qas
    Bettencourt, Richele
    Ajmera, Veeral
    Valasek, Mark A.
    Behling, Cynthia
    Loomba, Rohit
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (12) : 2673 - +
  • [36] Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease
    Colin Feuille
    Swathi Kari
    Roshan Patel
    Rohan Oberoi
    Jonathan Liu
    Michael Ohliger
    Mandana Khalili
    Michele Tana
    Scientific Reports, 14
  • [37] Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease
    Feuille, Colin
    Kari, Swathi
    Patel, Roshan
    Oberoi, Rohan
    Liu, Jonathan
    Ohliger, Michael
    Khalili, Mandana
    Tana, Michele
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [38] Diagnostic Power of Fibroscan in Predicting Liver Fibrosis in Nonalcoholic Fatty Liver Disease
    Alisi, Anna
    Pinzani, Massimo
    Nobili, Valerio
    HEPATOLOGY, 2009, 50 (06) : 2048 - 2049
  • [39] CLINICAL DETERMINANTS OF FIBROSIS PROGRESSION IN AN ITALIAN PROSPECTIVE COHORT OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Lombardi, R.
    Pelusi, S.
    Hyseni, E.
    Borroni, V.
    Fracanzani, A. L.
    Fargion, S.
    Valenti, L.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E43 - E44
  • [40] CLINICAL DETERMINANTS OF FIBROSIS PROGRESSION IN AN ITALIAN PROSPECTIVE COHORT OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Pelusi, S.
    Lombardi, R.
    Hyseni, E.
    Borroni, V.
    Fracanzani, A. L.
    Fargion, S.
    Valenti, L.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S497 - S498